Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
Tesamorelin
Growth-hormone-releasing-factor analogue research material
- GHRH receptor
- Endocrine signalling
- Approved-product distinction
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is Tesamorelin?
Tesamorelin is a stabilised growth-hormone-releasing-factor analogue used to study GHRH-receptor signalling and the downstream GH/IGF-1 axis. The active moiety has an approved pharmaceutical context in the United States, but generic Bear Biotech research material is not that medicine and should not inherit its clinical claims.
Approved active moiety in a specific U.S. product; research vial is not that product
Research focus
Key research areas
Tesamorelin research: GHRF signalling and the GH/IGF-1 axis
Tesamorelin is a stabilised growth-hormone-releasing-factor analogue. Evidence for a defined regulated formulation does not establish equivalence of generic research powder. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- GHRH receptor
- Endocrine signalling
- Approved-product distinction
Representative primary research
Representative research
Two phase-3 studies investigated a regulated tesamorelin product in antiretroviral-treated adults.
- Effects of tesamorelin (TH9507): pooled analysis of two phase 3 trials ↗ The pharmaceutical trial product does not verify equivalence of catalogue research material.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- Tesamorelin
- Research category
- Growth-hormone-releasing-factor analogue research material
- Evidence position
- Approved active moiety in a specific U.S. product; research vial is not that product
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
How does Tesamorelin engage GHRH-receptor signalling?
Tesamorelin research examines GHRH-receptor signalling and downstream endocrine responses. Its identity also has a specific approved-product context.
Why does Tesamorelin’s approved-product context matter when reading research?
Endocrine signalling studies measure defined pituitary and metabolic endpoints under controlled protocols. They should not be generalised beyond the tested formulation.
Why is a generic Tesamorelin research vial not the approved formulation?
Tesamorelin is an approved active moiety in a specific United States product, but a research vial is not that product. Evidence must preserve this distinction.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.